Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies - PubMed (original) (raw)

. 2002 Apr 12;277(15):12680-8.

doi: 10.1074/jbc.M109839200. Epub 2002 Jan 28.

Affiliations

• PMID: 11815607
• DOI: 10.1074/jbc.M109839200

Free article

Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies

Xiang-qun Chen et al. J Biol Chem. 2002.

Free article

Abstract

Rho-binding kinase alpha (ROKalpha) is a serine/threonine kinase with multiple functional domains involved in actomyosin assembly. It has previously been documented that the C terminus part of ROKalpha interacts with the N-terminal kinase domain and thereby regulates its catalytic activity. Here we used antibodies against different domains of ROKalpha and were able to reveal some structural aspects that are essential for the specific functions of ROKalpha. Antibodies against the kinase domain revealed that this part of the protein is highly complex and inaccessible. Further experiments confirmed that this domain could undergo inter- and intramolecular interactions in a complex manner, which regulates the kinase catalytic activity. Other antibodies that raised against the coiled-coil domain, Rho binding domain, and the pleckstrin homology (PH) domain were all effective in recognizing the native proteins in an immunoprecipitation assay. Only the anti-Rho binding domain antibodies could activate the kinase independent of RhoA. The PH antibodies had no apparent effects on the catalytic activity but were effective in blocking actomyosin assembly and cell contractility. Likewise, mutations of the PH domains can abrogate its dominant negative effects on actin morphology. The subsequent disruption of endogenous ROK localization to the actomyosin network by overexpressing the PH domain is supportive of a role of the PH domain of ROK in targeting the kinase to these structures.

PubMed Disclaimer

Similar articles

• The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.
  Leung T, Chen XQ, Manser E, Lim L. Leung T, et al. Mol Cell Biol. 1996 Oct;16(10):5313-27. doi: 10.1128/MCB.16.10.5313. Mol Cell Biol. 1996. PMID: 8816443 Free PMC article.
• p80 ROKalpha binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology.
  Leung T, Ng Y, Cheong A, Ng CH, Tan I, Hall C, Lim L. Leung T, et al. FEBS Lett. 2002 Dec 18;532(3):445-9. doi: 10.1016/s0014-5793(02)03736-5. FEBS Lett. 2002. PMID: 12482610
• Dynamics of RhoA and ROKalpha translocation in single living cells.
  Miyazaki K, Komatsu S, Ikebe M. Miyazaki K, et al. Cell Biochem Biophys. 2006;45(3):243-54. doi: 10.1385/CBB:45:3:243. Cell Biochem Biophys. 2006. PMID: 16845171
• RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network.
  Sin WC, Chen XQ, Leung T, Lim L. Sin WC, et al. Mol Cell Biol. 1998 Nov;18(11):6325-39. doi: 10.1128/MCB.18.11.6325. Mol Cell Biol. 1998. PMID: 9774649 Free PMC article.
• p160 RhoA-binding kinase ROKalpha induces neurite retraction.
  Katoh H, Aoki J, Ichikawa A, Negishi M. Katoh H, et al. J Biol Chem. 1998 Jan 30;273(5):2489-92. doi: 10.1074/jbc.273.5.2489. J Biol Chem. 1998. PMID: 9446546

Cited by

• The interaction between Shroom3 and Rho-kinase is required for neural tube morphogenesis in mice.
  Das D, Zalewski JK, Mohan S, Plageman TF, VanDemark AP, Hildebrand JD. Das D, et al. Biol Open. 2014 Aug 29;3(9):850-60. doi: 10.1242/bio.20147450. Biol Open. 2014. PMID: 25171888 Free PMC article.
• Physiological role of ROCKs in the cardiovascular system.
  Noma K, Oyama N, Liao JK. Noma K, et al. Am J Physiol Cell Physiol. 2006 Mar;290(3):C661-8. doi: 10.1152/ajpcell.00459.2005. Am J Physiol Cell Physiol. 2006. PMID: 16469861 Free PMC article. Review.
• Rho kinase (ROCK) inhibitors.
  Liao JK, Seto M, Noma K. Liao JK, et al. J Cardiovasc Pharmacol. 2007 Jul;50(1):17-24. doi: 10.1097/FJC.0b013e318070d1bd. J Cardiovasc Pharmacol. 2007. PMID: 17666911 Free PMC article. Review.
• RhoE binds to ROCK I and inhibits downstream signaling.
  Riento K, Guasch RM, Garg R, Jin B, Ridley AJ. Riento K, et al. Mol Cell Biol. 2003 Jun;23(12):4219-29. doi: 10.1128/MCB.23.12.4219-4229.2003. Mol Cell Biol. 2003. PMID: 12773565 Free PMC article.
• A molecular mechanism of P-loop pliability of Rho-kinase investigated by molecular dynamic simulation.
  Gohda K, Hakoshima T. Gohda K, et al. J Comput Aided Mol Des. 2008 Nov;22(11):789-97. doi: 10.1007/s10822-008-9214-7. Epub 2008 Apr 15. J Comput Aided Mol Des. 2008. PMID: 18415022

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database